# Pristiq Extended-Release

NDC: 0008-1222
Generic name: desvenlafaxine succinate
Labeler / Manufacturer: Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20080501

FDA application: NDA021992

## Active ingredients

- DESVENLAFAXINE SUCCINATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0008-1222"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0008-1222
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0f43610c-f290-46ea-d186-4f998ed99fce